Tuesday, 22 July 2014

Study Guide: Chapter 1, Q1-2

Avita Medical Ltd

Assets

Cash on hand 31st December 2013: $6.8M
(funds available)

Funds Granted for clinical Trials $880K

Total Revenue FY13: $2.81M

Liabilities

Cost of sale FY13: $676,502
Total costs (inputs) accumulated out of total revenue (outputs)

Equity option CEO: $31,581
Share given to CEO as yearly bonus

Corporate Charges: $1.5M
Cost incurred by the company for items not directly involved in capital expenditure

Equity

Market Capitalisation: $42M
Total value of issued shares

Contributed equity: $111,441,390
Positive share holders equity

Accumulated losses: $ 101,706,766
Negative share holder equity
Posted by at

4 comments:

  1. Unknown22 July 2014 at 14:31

    Hi Ronnie. Like the way you have set this out. Good explanations and easy to understand. Look forward to reading more about your company.

    ReplyDelete
  2. Ronnie Giandzi23 July 2014 at 03:07

    Thanks Adrian :)

    ReplyDelete
  3. Unknown25 July 2014 at 01:43

    Hi. I found it easy to understand as well. Have a look at how I have put these at my blog and let me know if you understand it-:
    http://maialkanthani.blogspot.com.au/

    ReplyDelete
  4. Unknown25 July 2014 at 10:49

    Hey Ronnie,

    Thanks for the prompt in the forum :)

    Well set out and I agree easy to understand. I hope I've got mine right...
    My blog address if you get time is

    http://stephneyfitzgerald.blogspot.com.au/

    cheers steph

    ReplyDelete

Subscribe to: Post Comments (Atom)